Publications by authors named "Baha Sharaf"

Claim this Profile
M
Metastasis-Directed Stereotactic Body Radiation Therapy in Oligometastatic and Oligoprogressive Solid Malignancy: Outcomes and Effect on Systemic Treatment.
Abdulla Alzibdeh, Lina Wahbeh, Shatha Abu Taha, Mohamed Qambar, Abdelatif Al Mousa, Baha Sharaf

JCO Glob Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing Early Detection of Pancreatic Cancer in Genetically Predisposed Individuals: Integrating Advanced Imaging Modalities with Emerging Biomarkers and Liquid Biopsy.
Rashid Abdel-Razeq, Asem Mansour, Maha Barbar, Mayada Abu Shanap, Baha Sharaf

Biologics· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update in the clinical utilization of chemoprevention for breast cancer: a narrative review.
Razan Mansour, Mahmoud Abunasser, Baha' Sharaf, Hikmat Abdel-Razeq

Front Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the link between mutation and breast cancer in a Jordanian Arab population.
Baha Sharaf, Hira Bani Hani, Anas Zayed, Maha Barbar, Suhaib Khater

Front Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Anti-HER2 Therapy Vs Trastuzumab Alone with Neoadjuvant Anthracycline and Taxane in HER2-Positive Early-Stage Breast Cancer: Real-World Insights.
Baha Sharaf, Faris Tamimi, Haneen Al-Abdallat, Suhaib Khater, Osama Salama

Biologics· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escalation and De-Escalation Strategies for Endocrine Therapy in Early-Stage Breast Cancer.
Tamer Al-Batsh, Nayef Abdel-Razeq, Yosra Al-Masri, Osama El-Khatib, Baha Sharaf

Biologics· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peculiar Pattern of Response Following [225Ac]Ac-PSMA Therapy: A Case Report with 'PSA Pseudoregression' Response Pattern.
Akram Al-Ibraheem, Feras Istatieh, Ahmed Saad Abdlkadir, Alaa' Abufara, Baha Sharaf

Nuklearmedizin· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Gene Panel Testing for Hereditary Cancer Predisposition Among Patients Sixty-Five Years and Above Diagnosed With Breast Cancer.
Hikmat Abdel-Razeq, Faris Tamimi, Baha Sharaf, Sarah M Nielsen, Brandie Heald

World J Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and Frequency of Pathogenic Germline Variants Among Prostate Cancer Patients Utilizing Multi-Gene Panel Genetic Testing.
Ramiz Abu Hijlih, Baha Sharaf, Samer Salah, Hira Bani Hani, Sarah M Nielsen

World J Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a clinical cancer genetics program for breast cancer in a resource-limited country; challenges and opportunities.
Hikmat Abdel-Razeq, Baha Sharaf, Faris Tamimi, Hira Bani Hani, Osama Alsmadi

Front Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Patients Treated with Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant for HR-Positive, HER2-Negative Metastatic Breast Cancer, Real-World Data from a Low-Resourced Country.
Hikmat Abdel-Razeq, Baha Sharaf, Suhaib Khater, Huda Jafar Baidoun, Hira Bani Hani

Immunotargets Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and Frequency of Pathogenic Germline Mutations among Patients with Newly-Diagnosed Endometrial Cancer: The Jordanian Exploratory Cancer Genetics (Jo-ECAG) Endometrial Study.
Hikmat Abdel-Razeq, Hira Bani Hani, Baha Sharaf, Faris Tamimi, Hanan Khalil

Cancers (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic counseling and genetic testing for pathogenic germline mutations among high-risk patients previously diagnosed with breast cancer: a traceback approach.
Hikmat Abdel-Razeq, Faris Tamimi, Sereen Iweir, Baha Sharaf, Sarah Abdel-Razeq

Sci Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of Universal Pan-Cancer Germline Genetic Testing in an Arab Population: The Jordanian Exploratory Cancer Genetics Study.
Hikmat Abdel-Razeq, Baha' Sharaf, Hira Bani Hani, Ramiz Abu Hijlih, Mais Alkyam

JCO Glob Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next generation selective estrogen receptor degraders in postmenopausal women with advanced-stage hormone receptors-positive, HER2-negative breast cancer.
Baha' Sharaf, Abdelrahman Hajahjeh, Hira Bani Hani, Hikmat Abdel-Razeq

Front Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Despair to Hope: First Arabic Experience of Lu-PSMA and Tb-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer.
Akram Al-Ibraheem, Ahmed Saad Abdlkadir, Deya' Aldeen Sweedat, Stephan Maus, Ula Al-Rasheed, Baha' Sharaf

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Genetic Mutations in Adult Patients with Sarcoma: Insight into the Middle East Genetic Landscape.
Ramiz Abu-Hijlih, Baha Sharaf, Samer Salah, Hira Bani Hani, Mohammad Alqaisieh

Cancers (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral venous sinus thrombosis in a patient treated with ribociclib for metastatic breast cancer. Case reports and literature review.
Baha Sharaf, Zeina Othman, Hala Abu Faris, Malak Al-Bitar, Qasem Al-Zoubi

SAGE Open Med Case Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Outcomes after Placement of Inferior Vena Cava Filters in Cancer Patients: Insights from a Comprehensive Cancer Center's Experience.
Hikmat Abdel-Razeq, Faris Tamimi, Mohammed J Al-Jaghbeer, Baha' Sharaf, Rashid Abdel-Razeq

J Clin Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study.
Hikmat Abdel-Razeq, Baha' Sharaf, Mohammed J Al-Jaghbeer, Hala Abu-Fares, Rayan Bater

J Thromb Thrombolysis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Treatment Outcomes Between Patients with HER2-Low versus HER2-Zero, Hormone Receptor-Positive Advanced-Stage Breast Cancer Treated with Ribociclib.
Baha' Sharaf, Hala Abu-Fares, Faris Tamimi, Suhaib Al-Sawajneh, Osama Salama

Breast Cancer (Dove Med Press)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo-ECAG) ovarian study.
Hikmat Abdel-Razeq, Khansa Al-Azzam, Shatha Elemian, Hala Abu-Fares, Areej Abu Sheikha, Baha' Sharaf

Mol Genet Genomic Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer.
Hikmat Abdel-Razeq, Lama Abujamous, Khansa Al-Azzam, Hala Abu-Fares, Hira Bani Hani, Baha' Sharaf

Breast Cancer (Dove Med Press)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Durable Response of Primary Advanced Colonic Plasmacytoma Using a Combination of Surgical Resection and Adjuvant Bortezomib: A Case Report and Literature Review.
Rozan Alfar, Nazmi Kamal, Rashid Abdel Razeq, Zaid Omari, Rayan Bater, Baha' Sharaf

Onco Targets Ther· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow involvement in patients with metastatic castration sensitive prostate cancer.
Mohammed Shahait, Ramiz Abu-Hijlih, Alaa Salamat, Nassib Abou Heidar, Baha' Sharaf

PLoS One· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis